Author Archives: admin

Paxlovid causes rebound COVID 25% of the time

January 7, 2024- by Steven E. Greer, MD

Posted in - Pharma, CDC, Emergency medicine, Infectious disease | Leave a comment

Putrid food of the 19th Century

November 29, 2023- by Steven E. Greer, MD I have been watching a 48-part lecture by a University of Virginia historian on the Civil

Posted in - Opinion, - Reviews, books, devices, Bariatric surgery, FDA | Leave a comment

The slippery slope of stifling free speech

December 10, 2023- by Steven E. Greer, MD

Posted in - Opinion, - Policy | Leave a comment

Oral arguments in Cortex Television v. New York State Dept Health, Index No. 318612 (Sup. Ct., Albany Cnty. 2022)

October 18, 2023

Posted in - Policy | Leave a comment

How to establish a face transplant team

Update December 1, 2018- Dr. Rodriguez and his team of at least 100 surgeons, psychiatrists, social

Posted in - Policy, NYU, Plastic surgery | Leave a comment

Exclusive: The gender reassignment butchers have taken over my NYU surgery

September 5, 2023- by Steven E. Greer, MD Opinion-

Posted in - Opinion, CMS, Congress, Obstetrics and Gynecology, Pediatrics, Plastic surgery, Primary care medicine, Psychology Psychiatry | 1 Comment

The long and winding road of the Ventilator Death paper (Perseverance Prevails)

November 1, 2023- by Steven E. Greer, MD

Posted in - JAMA, - Medical Devices, - Opinion, - Policy | Leave a comment

Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity

September 1, 2023- by Sucharit Bhakdi, MD et al

Posted in - Biotech, - Pharma, - Reviews, books, devices, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology, Pediatrics | Leave a comment

Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)

Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.

Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease | Leave a comment

Ivermectin works against COVID in double blind, randomized, controlled trial

May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.

Posted in - Biotech, - Generics, - Pharma, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine | Leave a comment

Steven E. Greer, MD on OANN discussing virus therapies

April 16, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, CDC, CMS, Congress, Emergency medicine, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Pediatrics, Primary care medicine, Pulmonology, VA | Leave a comment

Did the COVID vaccines change the human genome?

May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology | Leave a comment

Rudy Giuliani interviews Steven E. Greer, MD on WABC radio- May 6, 2020

May 6, 2020

Posted in - Opinion, - Policy, CDC, CMS, Congress, Emergency medicine, FDA, Infectious disease, NIH | Leave a comment

That time I worked with Lucas Films to push digital cameras into the mainstream

November 11, 2023- by Steven E. Greer, MD

Posted in - Medical Devices, - Opinion, Plastic surgery | Leave a comment

Federal appeals court rules that our federal government violated the First Amendment during the pandemic

September 8, 2023- by Steven Greer (pro se litigator extraordinaire)

Posted in - Opinion, CDC, CMS, Congress, FDA, NIH | Leave a comment

The Healthcare Channel hits 10

February 3, 2017- by Steven E. Greer, MD I don’t recall the exact date, but it was sometime during the summer of 2006, when I was daydreaming

Posted in - Opinion | Leave a comment

The Miami Summit on Healthcare Spending Reduction

June 29, 2010 Produced and interviewed by Steven Greer, MD The Healthcare Channel and The University of Miami Health System hosted a roundtable discussion

Posted in - Policy, CMS, Congress, Univ Miami | Leave a comment

Joe Piscopo interviews Steven E. Greer, MD: 5-22-2020

May 22, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Pulmonology | Leave a comment

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer,

Posted in - Biotech, - Generics, FDA | Leave a comment